Global Cancer Vaccine Market Research Report 2020

This report focuses on Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

    Dendreon Corporation

    NeoStem Oncology

    ImmunoGen

    Inovio Pharmaceuticals

    Novartis

    ...

    North America

    Europe

    China

    Japan

    Preventive vaccines

    Therapeutic vaccines

    Prostate Cancer

    Cervical Cancer

    Others

Table of Contents

1.1 Product Overview and Scope of Cancer Vaccine

1.2 Cancer Vaccine Segment by Type

1.2.1 Global Cancer Vaccine Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Preventive vaccines

1.2.3 Therapeutic vaccines

1.3 Cancer Vaccine Segment by Application

1.3.1 Cancer Vaccine Sales Comparison by Application: 2020 VS 2026

1.3.2 Prostate Cancer

1.3.3 Cervical Cancer

1.3.4 Others

1.4 Global Cancer Vaccine Market Size Estimates and Forecasts

1.4.1 Global Cancer Vaccine Revenue 2015-2026

1.4.2 Global Cancer Vaccine Sales 2015-2026

1.4.3 Cancer Vaccine Market Size by Region: 2020 Versus 2026

2.1 Global Cancer Vaccine Sales Market Share by Manufacturers (2015-2020)

2.2 Global Cancer Vaccine Revenue Share by Manufacturers (2015-2020)

2.3 Global Cancer Vaccine Average Price by Manufacturers (2015-2020)

2.4 Manufacturers Cancer Vaccine Manufacturing Sites, Area Served, Product Type

2.5 Cancer Vaccine Market Competitive Situation and Trends

2.5.1 Cancer Vaccine Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key Cancer Vaccine Players (Opinion Leaders)

3.1 Global Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America Cancer Vaccine Market Facts & Figures by Country

3.3.1 North America Cancer Vaccine Sales by Country

3.3.2 North America Cancer Vaccine Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Cancer Vaccine Market Facts & Figures by Country

3.4.1 Europe Cancer Vaccine Sales by Country

3.4.2 Europe Cancer Vaccine Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Cancer Vaccine Market Facts & Figures by Region

3.5.1 Asia Pacific Cancer Vaccine Sales by Region

3.5.2 Asia Pacific Cancer Vaccine Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Cancer Vaccine Market Facts & Figures by Country

3.6.1 Latin America Cancer Vaccine Sales by Country

3.6.2 Latin America Cancer Vaccine Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa Cancer Vaccine Market Facts & Figures by Country

3.7.1 Middle East and Africa Cancer Vaccine Sales by Country

3.7.2 Middle East and Africa Cancer Vaccine Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global Cancer Vaccine Sales Market Share by Type (2015-2020)

4.2 Global Cancer Vaccine Revenue Market Share by Type (2015-2020)

4.3 Global Cancer Vaccine Price Market Share by Type (2015-2020)

4.4 Global Cancer Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Cancer Vaccine Sales Market Share by Application (2015-2020)

5.2 Global Cancer Vaccine Revenue Market Share by Application (2015-2020)

5.3 Global Cancer Vaccine Price by Application (2015-2020)

6.1 Dendreon Corporation

6.1.1 Corporation Information

6.1.2 Dendreon Corporation Description, Business Overview and Total Revenue

6.1.3 Dendreon Corporation Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Dendreon Corporation Products Offered

6.1.5 Dendreon Corporation Recent Development

6.2 NeoStem Oncology

6.2.1 NeoStem Oncology Cancer Vaccine Production Sites and Area Served

6.2.2 NeoStem Oncology Description, Business Overview and Total Revenue

6.2.3 NeoStem Oncology Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.2.4 NeoStem Oncology Products Offered

6.2.5 NeoStem Oncology Recent Development

6.3 ImmunoGen

6.3.1 ImmunoGen Cancer Vaccine Production Sites and Area Served

6.3.2 ImmunoGen Description, Business Overview and Total Revenue

6.3.3 ImmunoGen Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.3.4 ImmunoGen Products Offered

6.3.5 ImmunoGen Recent Development

6.4 Inovio Pharmaceuticals

6.4.1 Inovio Pharmaceuticals Cancer Vaccine Production Sites and Area Served

6.4.2 Inovio Pharmaceuticals Description, Business Overview and Total Revenue

6.4.3 Inovio Pharmaceuticals Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Inovio Pharmaceuticals Products Offered

6.4.5 Inovio Pharmaceuticals Recent Development

6.5 Novartis

6.5.1 Novartis Cancer Vaccine Production Sites and Area Served

6.5.2 Novartis Description, Business Overview and Total Revenue

6.5.3 Novartis Cancer Vaccine Sales, Revenue and Gross Margin (2015-2020)

6.5.4 Novartis Products Offered

6.5.5 Novartis Recent Development

7.1 Cancer Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Cancer Vaccine

7.4 Cancer Vaccine Industrial Chain Analysis

8.1 Marketing Channel

8.2 Cancer Vaccine Distributors List

8.3 Cancer Vaccine Customers

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

10.1 Global Cancer Vaccine Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Cancer Vaccine by Type (2021-2026)

10.1.2 Global Forecasted Revenue of Cancer Vaccine by Type (2021-2026)

10.2 Cancer Vaccine Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Cancer Vaccine by Application (2021-2026)

10.2.2 Global Forecasted Revenue of Cancer Vaccine by Application (2021-2026)

10.3 Cancer Vaccine Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Cancer Vaccine by Region (2021-2026)

10.3.2 Global Forecasted Revenue of Cancer Vaccine by Region (2021-2026)

10.4 North America Cancer Vaccine Estimates and Projections (2021-2026)

10.5 Europe Cancer Vaccine Estimates and Projections (2021-2026)

10.6 Asia Pacific Cancer Vaccine Estimates and Projections (2021-2026)

10.7 Latin America Cancer Vaccine Estimates and Projections (2021-2026)

10.8 Middle East and Africa Cancer Vaccine Estimates and Projections (2021-2026)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global Cancer Vaccine Sales (MT) Growth Rate Comparison by Type (2015-2026)

    Table 2. Global Cancer Vaccine Sales (MT) Comparison by Application: 2020 VS 2026

    Table 3. Global Cancer Vaccine Market Size by Type (MT) (US$ Million) (2020 VS 2026)

    Table 4. Global Key Cancer Vaccine Manufacturers Covered in This Study

    Table 5. Global Cancer Vaccine Sales (MT) by Manufacturers (2015-2020)

    Table 6. Global Cancer Vaccine Sales Share by Manufacturers (2015-2020)

    Table 7. Global Cancer Vaccine Revenue (Million USD) by Manufacturers (2015-2020)

    Table 8. Global Cancer Vaccine Revenue Share by Manufacturers (2015-2020)

    Table 9. Global Market Cancer Vaccine Average Price (USD/MT) of Key Manufacturers (2015-2020)

    Table 10. Manufacturers Cancer Vaccine Sales Sites and Area Served

    Table 11. Manufacturers Cancer Vaccine Product Types

    Table 12. Global Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Vaccine as of 2019)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Main Points Interviewed from Key Cancer Vaccine Players

    Table 16. Global Cancer Vaccine Sales (MT) by Region (2015-2020)

    Table 17. Global Cancer Vaccine Sales Market Share by Region (2015-2020)

    Table 18. Global Cancer Vaccine Revenue (Million US$) by Region (2015-2020)

    Table 19. Global Cancer Vaccine Revenue Market Share by Region (2015-2020)

    Table 20. North America Cancer Vaccine Sales by Country (2015-2020) (MT)

    Table 21. North America Cancer Vaccine Sales Market Share by Country (2015-2020)

    Table 22. North America Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 23. North America Cancer Vaccine Revenue Market Share by Country (2015-2020)

    Table 24. Europe Cancer Vaccine Sales by Country (2015-2020) (MT)

    Table 25. Europe Cancer Vaccine Sales Market Share by Country (2015-2020)

    Table 26. Europe Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 27. Europe Cancer Vaccine Revenue Market Share by Country (2015-2020)

    Table 28. Asia Pacific Cancer Vaccine Sales by Region (2015-2020) (MT)

    Table 29. Asia Pacific Cancer Vaccine Sales Market Share by Region (2015-2020)

    Table 30. Asia Pacific Cancer Vaccine Revenue by Region (2015-2020) (US$ Million)

    Table 31. Asia Pacific Cancer Vaccine Revenue Market Share by Region (2015-2020)

    Table 32. Latin America Cancer Vaccine Sales by Country (2015-2020) (MT)

    Table 33. Latin America Cancer Vaccine Sales Market Share by Country (2015-2020)

    Table 34. Latin America Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 35. Latin America Cancer Vaccine Revenue Market Share by Country (2015-2020)

    Table 36. Middle East and Africa Cancer Vaccine Sales by Country (2015-2020) (MT)

    Table 37. Middle East and Africa Cancer Vaccine Sales Market Share by Country (2015-2020)

    Table 38. Middle East and Africa Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)

    Table 39. Middle East and Africa Cancer Vaccine Revenue Market Share by Country (2015-2020)

    Table 40. Global Cancer Vaccine Sales (MT) by Type (2015-2020)

    Table 41. Global Cancer Vaccine Sales Share by Type (2015-2020)

    Table 42. Global Cancer Vaccine Revenue (Million US$) by Type (2015-2020)

    Table 43. Global Cancer Vaccine Revenue Share by Type (2015-2020)

    Table 44. Global Cancer Vaccine Price (USD/MT) by Type (2015-2020)

    Table 45. Global Cancer Vaccine Sales (MT) by Application (2015-2020)

    Table 46. Global Cancer Vaccine Sales Market Share by Application (2015-2020)

    Table 47. Global Cancer Vaccine Sales Growth Rate by Application (2015-2020)

    Table 48. Dendreon Corporation Cancer Vaccine Corporation Information

    Table 49. Dendreon Corporation Description and Business Overview

    Table 50. Dendreon Corporation Cancer Vaccine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 51. Dendreon Corporation Main Product

    Table 52. Dendreon Corporation Recent Development

    Table 53. NeoStem Oncology Cancer Vaccine Corporation Information

    Table 54. NeoStem Oncology Corporation Information

    Table 55. NeoStem Oncology Cancer Vaccine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 56. NeoStem Oncology Main Product

    Table 57. NeoStem Oncology Recent Development

    Table 58. ImmunoGen Cancer Vaccine Corporation Information

    Table 59. ImmunoGen Corporation Information

    Table 60. ImmunoGen Cancer Vaccine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 61. ImmunoGen Main Product

    Table 62. ImmunoGen Recent Development

    Table 63. Inovio Pharmaceuticals Cancer Vaccine Corporation Information

    Table 64. Inovio Pharmaceuticals Corporation Information

    Table 65. Inovio Pharmaceuticals Cancer Vaccine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 66. Inovio Pharmaceuticals Main Product

    Table 67. Inovio Pharmaceuticals Recent Development

    Table 68. Novartis Cancer Vaccine Corporation Information

    Table 69. Novartis Corporation Information

    Table 70. Novartis Cancer Vaccine Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 71. Novartis Main Product

    Table 72. Novartis Recent Development

    Table 73. Sales Base and Market Concentration Rate of Raw Material

    Table 74. Key Suppliers of Raw Materials

    Table 75. Cancer Vaccine Distributors List

    Table 76. Cancer Vaccine Customers List

    Table 77. Market Key Trends

    Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 79. Key Challenges

    Table 80. Global Cancer Vaccine Sales (MT) Forecast by Type (2021-2026)

    Table 81. Global Cancer Vaccine Sales Market Share Forecast by Type (2021-2026)

    Table 82. Global Cancer Vaccine Revenue (Million US$) Forecast by Type (2021-2026)

    Table 83. Global Cancer Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)

    Table 84. Global Cancer Vaccine Sales (MT) Forecast by Application (2021-2026)

    Table 85. Global Cancer Vaccine Revenue (Million US$) Forecast by Application (2021-2026)

    Table 86. Global Cancer Vaccine Sales (MT) Forecast by Region (2021-2026)

    Table 87. Global Cancer Vaccine Sales Market Share Forecast by Region (2021-2026)

    Table 88. Global Cancer Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 89. Global Cancer Vaccine Revenue Market Share Forecast by Region (2021-2026)

    Table 90. Research Programs/Design for This Report

    Table 91. Key Data Information from Secondary Sources

    Table 92. Key Data Information from Primary Sources

List of Figures

    Figure 1. Picture of Cancer Vaccine

    Figure 2. Global Cancer Vaccine Sales Market Share by Type: 2020 VS 2026

    Figure 3. Preventive vaccines Product Picture

    Figure 4. Therapeutic vaccines Product Picture

    Figure 5. Global Cancer Vaccine Consumption Market Share by Application: 2020 VS 2026

    Figure 6. Prostate Cancer

    Figure 7. Cervical Cancer

    Figure 8. Others

    Figure 9. Global Cancer Vaccine Market Size 2015-2026 (US$ Million)

    Figure 10. Global Cancer Vaccine Sales Capacity (MT) (2015-2026)

    Figure 11. Global Cancer Vaccine Market Size Market Share by Region: 2020 Versus 2026

    Figure 12. Cancer Vaccine Sales Share by Manufacturers in 2020

    Figure 13. Global Cancer Vaccine Revenue Share by Manufacturers in 2019

    Figure 14. The Global 5 and 10 Largest Players: Market Share by Cancer Vaccine Revenue in 2019

    Figure 15. Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 16. Global Cancer Vaccine Sales Market Share by Region (2015-2020)

    Figure 17. Global Cancer Vaccine Sales Market Share by Region in 2019

    Figure 18. Global Cancer Vaccine Revenue Market Share by Region (2015-2020)

    Figure 19. Global Cancer Vaccine Revenue Market Share by Region in 2019

    Figure 20. North America Cancer Vaccine Sales Market Share by Country in 2019

    Figure 21. North America Cancer Vaccine Revenue Market Share by Country in 2019

    Figure 22. U.S. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 23. U.S. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 24. Canada Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 25. Canada Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 26. Europe Cancer Vaccine Sales Market Share by Country in 2019

    Figure 27. Europe Cancer Vaccine Revenue Market Share by Country in 2019

    Figure 28. Germany Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 29. Germany Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 30. France Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 31. France Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 32. U.K. Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 33. U.K. Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 34. Italy Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 35. Italy Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 36. Russia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 37. Russia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 38. Asia Pacific Cancer Vaccine Sales Market Share by Region in 2019

    Figure 39. Asia Pacific Cancer Vaccine Revenue Market Share by Region in 2019

    Figure 40. China Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 41. China Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 42. Japan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 43. Japan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 44. South Korea Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 45. South Korea Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 46. India Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 47. India Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 48. Australia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 49. Australia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 50. Taiwan Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 51. Taiwan Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 52. Indonesia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 53. Indonesia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 54. Thailand Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 55. Thailand Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 56. Malaysia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 57. Malaysia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 58. Philippines Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 59. Philippines Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 60. Vietnam Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 61. Vietnam Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 62. Latin America Cancer Vaccine Sales Market Share by Country in 2019

    Figure 63. Latin America Cancer Vaccine Revenue Market Share by Country in 2019

    Figure 64. Mexico Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 65. Mexico Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 66. Brazil Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 67. Brazil Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 68. Argentina Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 69. Argentina Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 70. Middle East and Africa Cancer Vaccine Sales Market Share by Country in 2019

    Figure 71. Middle East and Africa Cancer Vaccine Revenue Market Share by Country in 2019

    Figure 72. Turkey Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 73. Turkey Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 74. Saudi Arabia Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 75. Saudi Arabia Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 76. U.A.E Cancer Vaccine Sales Growth Rate (2015-2020) (MT)

    Figure 77. U.A.E Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 78. Sales Market Share of Cancer Vaccine by Type (2015-2020)

    Figure 79. Sales Market Share of Cancer Vaccine by Type in 2019

    Figure 80. Revenue Share of Cancer Vaccine by Type (2015-2020)

    Figure 81. Revenue Market Share of Cancer Vaccine by Type in 2019

    Figure 82. Global Cancer Vaccine Sales Growth by Type (2015-2020) (MT)

    Figure 83. Global Cancer Vaccine Sales Market Share by Application (2015-2020)

    Figure 84. Global Cancer Vaccine Sales Market Share by Application in 2019

    Figure 85. Global Revenue Share of Cancer Vaccine by Application (2015-2020)

    Figure 86. Global Revenue Share of Cancer Vaccine by Application in 2020

    Figure 87. Dendreon Corporation Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 88. NeoStem Oncology Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 89. ImmunoGen Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 90. Inovio Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 91. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 92. Price Trend of Key Raw Materials

    Figure 93. Manufacturing Cost Structure of Cancer Vaccine

    Figure 94. Manufacturing Process Analysis of Cancer Vaccine

    Figure 95. Cancer Vaccine Industrial Chain Analysis

    Figure 96. Channels of Distribution

    Figure 97. Distributors Profiles

    Figure 98. Porter's Five Forces Analysis

    Figure 99. North America Cancer Vaccine Sales (MT) and Growth Rate Forecast (2021-2026)

    Figure 100. North America Cancer Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 101. Europe Cancer Vaccine Sales (MT) and Growth Rate Forecast (2021-2026)

    Figure 102. Europe Cancer Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 103. Latin America Cancer Vaccine Sales (MT) and Growth Rate Forecast (2021-2026)

    Figure 104. Latin America Cancer Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 105. Middle East and Africa Cancer Vaccine Sales (MT) and Growth Rate Forecast (2021-2026)

    Figure 106. Middle East and Africa Cancer Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 107. Asia Pacific Cancer Vaccine Sales (MT) and Growth Rate Forecast (2021-2026)

    Figure 108. Asia Pacific Cancer Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 109. Bottom-up and Top-down Approaches for This Report

    Figure 110. Data Triangulation

    Figure 111. Key Executives Interviewed